Niagen Bioscience
Los Angeles
About Niagen Bioscience
ChromaDex is a global nutraceutical company. They leverage their complementary business units to discover, acquire, develop, and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care, and pharmaceutical markets. They utilize in-house chemistry, regulatory, and safety consulting business units to develop commercially viable ingredients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $85.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2022)
- Ticker: nasdaq:NAGE
- Website: niagenbioscience.com
- Phone: +1 310 388 6706
Industries & Categories
Biotechnology, Manufacturing, Nutraceutical, Product Research, Wellness
Social Profiles
Canonical: https://fsome.com/organization/niagen-bioscience-41562 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.